Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Nihon Chouzai Co ( (JP:3341) ) just unveiled an update.
Nihon Chouzai Co., Ltd. announced corrections to its consolidated financial results for the fiscal year ending March 31, 2025, due to errors found during the preparation of their Annual Securities Report. These corrections primarily affect segment-related financial data, including net sales, segment profit, and asset adjustments, which are crucial for stakeholders to assess the company’s financial health and operational efficiency.
More about Nihon Chouzai Co
Nihon Chouzai Co., Ltd. operates in the healthcare sector, focusing on dispensing pharmacy services, pharmaceutical manufacturing and sales, and medical professional staffing and placement. The company is listed on the Tokyo Stock Exchange Prime Market.
Average Trading Volume: 315,224
Technical Sentiment Signal: Buy
Current Market Cap: Yen93.63B
Learn more about 3341 stock on TipRanks’ Stock Analysis page.